High RASSF1A promoter methylation levels are predictive of poor prognosis in fine-needle aspirate washings of breast cancer lesions

Author： Martins Ana   Monteiro Paula   Ramalho-Carvalho João   Costa Vera   Dinis-Ribeiro Mário   Leal Conceição   Henrique Rui   Jerónimo Carmen  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.129, Iss.1, 2011-08, pp. : 1-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Promoter methylation of BRCA1 in the prognosis of breast cancer: a meta-analysis

By Wu Liang   Wang Fengliang   Xu Ruobing   Zhang Simin   Peng Xianzhen   Feng Yan   Wang Jianming   Lu Cheng  

Breast Cancer Research and Treatment, Vol. 142, Iss. 3, 2013-12 ,pp. : 619-627

Springer Publishing Company

Access to resources Recommend Favorite

Methylated DNA and high total DNA levels in the serum of patients with breast cancer following neoadjuvant chemotherapy are predictive of a poor prognosis

By                        

Oncology Letters, Vol. 8, Iss. 1, 2014-01 ,pp. : 397-403

Spandidos Publications

Access to resources Recommend Favorite

Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer

By                        

International Journal of Oncology, Vol. 41, Iss. 2, 2012-01 ,pp. : 611-620

Spandidos Publications

Access to resources Recommend Favorite

Association of RASSF1A promoter methylation with gastric cancer risk: a meta-analysis

By Shi Dong-Tao   Han Mei   Gao Nan   Tian Wenyan   Chen Weichang  

Tumor Biology, Vol. 35, Iss. 2, 2014-02 ,pp. : 943-948

Springer Publishing Company

Access to resources Recommend Favorite

Elevated levels of HSF1 indicate a poor prognosis in breast cancer

By Calderwood Stuart K  

Future Oncology, Vol. 8, Iss. 4, 2012-04 ,pp. : 399-401

Future Medicine

Access to resources Recommend Favorite